| GO ID | GO:0007399 |
| Ontology | BP |
| GO Term | nervous system development |
| Definition | The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state. |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
|
DPYSL4 |
dihydropyrimidinase like 4 |
10570 |
O14531 |
chr10: 132,186,900-132,205,776 |
|
ENC1 |
ectodermal-neural cortex 1 (with BTB domain) |
8507 |
O14682 |
chr5: 74,627,406-74,641,424 |
|
TPP1 |
tripeptidyl peptidase I |
1200 |
O14773 |
chr11: 6,612,763-6,619,461 |
|
DCLK1 |
doublecortin like kinase 1 |
9201 |
O15075 |
chr13: 35,768,652-36,131,306 |
|
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
23543 |
O43251 |
chr22: 35,738,736-36,028,425 |
|
ITM2A |
integral membrane protein 2A |
9452 |
O43736 |
chrX: 79,360,384-79,367,667 |
|
ZEB2 |
zinc finger E-box binding homeobox 2 |
9839 |
O60315 |
chr2: 144,364,364-144,524,583 |
|
GAS7 |
growth arrest specific 7 |
8522 |
O60861 |
chr17: 9,910,609-10,198,551 |
|
SHOX2 |
short stature homeobox 2 |
6474 |
O60902 |
chr3: 158,095,954-158,106,503 |
|
SCRG1 |
stimulator of chondrogenesis 1 |
11341 |
O75711 |
chr4: 173,384,701-173,406,380 |
|
CSPG5 |
chondroitin sulfate proteoglycan 5 |
10675 |
O95196 |
chr3: 47,562,239-47,580,792 |
|
GDF11 |
growth differentiation factor 11 |
10220 |
O95390 |
chr12: 55,743,280-55,757,278 |
|
FGF19 |
fibroblast growth factor 19 |
9965 |
O95750 |
chr11: 69,698,232-69,704,642 |
|
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
2353 |
P01100 |
chr14: 75,278,774-75,282,230 |
|
APOB |
apolipoprotein B |
338 |
P04114 |
chr2: 21,001,429-21,044,073 |
|
INHA |
inhibin alpha |
3623 |
P05111 |
chr2: 219,569,162-219,575,713 |
|
CHRM2 |
cholinergic receptor, muscarinic 2 |
1129 |
P08172 |
chr7: 136,868,669-137,020,255 |
|
INHBA |
inhibin beta A |
3624 |
P08476 |
chr7: 41,667,168-41,705,834 |
|
FGF2 |
fibroblast growth factor 2 (basic) |
2247 |
P09038 |
chr4: 122,826,708-122,898,236 |
|
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
2919 |
P09341 |
chr4: 73,869,393-73,871,242 |
|
VEGFA |
vascular endothelial growth factor A |
7422 |
P15692 |
chr6: 43,770,184-43,786,487 |
|
NDUFV2 |
NADH:ubiquinone oxidoreductase core subunit V2 |
4729 |
P19404 |
chr18: 9,102,630-9,134,345 |
|
CHRM3 |
cholinergic receptor, muscarinic 3 |
1131 |
P20309 |
chr1: 239,386,565-239,915,452 |
|
MDK |
midkine (neurite growth-promoting factor 2) |
4192 |
P21741 |
chr11: 46,380,756-46,383,837 |
|
GAL |
galanin/GMAP prepropeptide |
51083 |
P22466 |
chr11: 68,683,779-68,691,175 |
|
CBLN1 |
cerebellin 1 precursor |
869 |
P23435 |
chr16: 49,277,917-49,281,831 |
|
BDNF |
brain-derived neurotrophic factor |
627 |
P23560 |
chr11: 27,654,893-27,722,058 |
|
EPHB2 |
EPH receptor B2 |
2048 |
P29323 |
chr1: 22,710,839-22,921,500 |
|
ADORA1 |
adenosine A1 receptor |
134 |
P30542 |
chr1: 203,090,654-203,167,405 |
|
SDHA |
succinate dehydrogenase complex subunit A, flavoprotein (Fp) |
6389 |
P31040 |
chr5: 218,241-256,700 |
|
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
6774 |
P40763 |
chr17: 42,313,324-42,388,568 |
|
NBL1 |
neuroblastoma 1, DAN family BMP antagonist |
4681 |
P41271 |
chr1: 19,640,554-19,658,456 |
|
GLRB |
glycine receptor beta |
2743 |
P48167 |
chr4: 157,076,057-157,172,090 |
|
PPT1 |
palmitoyl-protein thioesterase 1 |
5538 |
P50897 |
chr1: 40,071,461-40,097,727 |
|
SMARCA2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
6595 |
P51531 |
chr9: 1,980,290-2,193,624 |
|
SMARCA4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
6597 |
P51532 |
chr19: 10,961,001-11,065,395 |
|
EFNA5 |
ephrin-A5 |
1946 |
P52803 |
chr5: 107,376,889-107,670,895 |
|
ATXN3 |
ataxin 3 |
4287 |
P54252 |
chr14: 92,038,652-92,106,621 |
|
NAGLU |
N-acetylglucosaminidase, alpha |
4669 |
P54802 |
chr17: 42,536,172-42,544,449 |
|
DLX5 |
distal-less homeobox 5 |
1749 |
P56178 |
chr7: 97,020,392-97,025,097 |
|
HDAC4 |
histone deacetylase 4 |
9759 |
P56524 |
chr2: 239,048,168-239,401,654 |
|
PRPS1 |
phosphoribosyl pyrophosphate synthetase 1 |
5631 |
P60891 |
chrX: 107,628,424-107,651,026 |
|
FGF12 |
fibroblast growth factor 12 |
2257 |
P61328 |
chr3: 192,139,395-192,767,764 |
|
DLG4 |
discs, large homolog 4 (Drosophila) |
1742 |
P78352 |
chr17: 7,189,890-7,219,702 |
|
JAG1 |
jagged 1 |
182 |
P78504 |
chr20: 10,637,684-10,674,107 |
|
SIM1 |
single-minded family bHLH transcription factor 1 |
6492 |
P81133 |
chr6: 100,385,015-100,464,929 |
|
VLDLR |
very low density lipoprotein receptor |
7436 |
P98155 |
chr9: 2,621,834-2,660,053 |
|
PURA |
purine-rich element binding protein A |
5813 |
Q00577 |
chr5: 140,107,777-140,125,619 |
|
NDP |
Norrie disease (pseudoglioma) |
4693 |
Q00604 |
chrX: 43,948,776-43,973,504 |
|
SLC7A5 |
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
8140 |
Q01650 |
chr16: 87,830,023-87,869,488 |
|
NRG1 |
neuregulin 1 |
3084 |
Q02297 |
chr8: 31,639,386-32,767,959 |
|
APBA1 |
amyloid beta (A4) precursor protein-binding, family A, member 1 |
320 |
Q02410 |
chr9: 69,427,530-69,672,306 |
|
NOTCH2 |
notch 2 |
4853 |
Q04721 |
chr1: 119,911,553-120,069,626 |
|
MEF2C |
myocyte enhancer factor 2C |
4208 |
Q06413 |
chr5: 88,717,117-88,904,257 |
|
PCDH1 |
protocadherin 1 |
5097 |
Q08174 |
chr5: 141,853,111-141,879,246 |
|
EP300 |
E1A binding protein p300 |
2033 |
Q09472 |
chr22: 41,091,786-41,180,079 |
|
DLG1 |
discs, large homolog 1 (Drosophila) |
1739 |
Q12959 |
chr3: 197,042,560-197,299,300 |
|
LSAMP |
limbic system-associated membrane protein |
4045 |
Q13449 |
chr3: 115,802,363-117,139,389 |
|
GPM6B |
glycoprotein M6B |
2824 |
Q13491 |
chrX: 13,771,031-13,938,638 |
|
SEMA5A |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
9037 |
Q13591 |
chr5: 9,035,026-9,546,075 |
|
ARHGEF7 |
Rho guanine nucleotide exchange factor 7 |
8874 |
Q14155 |
chr13: 111,114,559-111,305,737 |
|
SIM2 |
single-minded family bHLH transcription factor 2 |
6493 |
Q14190 |
chr21: 36,699,133-36,749,917 |
|
DCTN1 |
dynactin subunit 1 |
1639 |
Q14203 |
chr2: 74,361,154-74,392,087 |
|
HES1 |
hes family bHLH transcription factor 1 |
3280 |
Q14469 |
chr3: 194,136,145-194,138,732 |
|
ELAVL3 |
ELAV like neuron-specific RNA binding protein 3 |
1995 |
Q14576 |
chr19: 11,451,326-11,481,046 |
|
PPP2R5D |
protein phosphatase 2 regulatory subunit B', delta |
5528 |
Q14738 |
chr6: 42,984,499-43,012,342 |
|
MEF2D |
myocyte enhancer factor 2D |
4209 |
Q14814 |
chr1: 156,463,727-156,500,828 |
|
PAFAH1B3 |
platelet activating factor acetylhydrolase 1b catalytic subunit 3 |
5050 |
Q15102 |
chr19: 42,297,033-42,303,546 |
|
ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
2066 |
Q15303 |
chr2: 211,375,717-212,538,841 |
|
MPPED2 |
metallophosphoesterase domain containing 2 |
744 |
Q15777 |
chr11: 30,384,493-30,586,872 |
|
DPYSL2 |
dihydropyrimidinase like 2 |
1808 |
Q16555 |
chr8: 26,514,022-26,658,178 |
|
CTF1 |
cardiotrophin 1 |
1489 |
Q16619 |
chr16: 30,896,607-30,903,560 |
|
ZNF423 |
zinc finger protein 423 |
23090 |
Q2M1K9 |
chr16: 49,487,524-49,857,919 |
|
TMEM41B |
transmembrane protein 41B |
440026 |
Q5BJD5 |
chr11: 9,280,654-9,314,780 |
|
CPLX2 |
complexin 2 |
10814 |
Q6PUV4 |
chr5: 175,796,310-175,884,020 |
|
GPSM1 |
G-protein signaling modulator 1 |
26086 |
Q86YR5 |
chr9: 136,327,476-136,359,605 |
|
RBM45 |
RNA binding motif protein 45 |
129831 |
Q8IUH3 |
chr2: 178,112,424-178,139,011 |
|
SIAH1 |
siah E3 ubiquitin protein ligase 1 |
6477 |
Q8IUQ4 |
chr16: 48,356,364-48,448,402 |
|
CNTN4 |
contactin 4 |
152330 |
Q8IWV2 |
chr3: 2,098,813-3,057,956 |
|
CHERP |
calcium homeostasis endoplasmic reticulum protein |
10523 |
Q8IWX8 |
chr19: 16,517,889-16,542,530 |
|
NLGN1 |
neuroligin 1 |
22871 |
Q8N2Q7 |
chr3: 173,396,284-174,286,644 |
|
ARID1B |
AT-rich interaction domain 1B |
57492 |
Q8NFD5 |
chr6: 156,777,374-157,210,779 |
|
CSGALNACT1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
55790 |
Q8TDX6 |
chr8: 19,404,161-19,758,029 |
|
PHF10 |
PHD finger protein 10 |
55274 |
Q8WUB8 |
chr6: 169,703,905-169,725,566 |
|
GPR98 |
adhesion G protein-coupled receptor V1 |
84059 |
Q8WXG9 |
chr5: 90,529,344-91,164,437 |
|
MYLIP |
myosin regulatory light chain interacting protein |
29116 |
Q8WY64 |
chr6: 16,129,125-16,148,248 |
|
ST8SIA4 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
7903 |
Q92187 |
chr5: 100,806,935-100,903,266 |
|
DPF3 |
D4, zinc and double PHD fingers, family 3 |
8110 |
Q92784 |
chr14: 72,619,296-72,894,116 |
|
FGF13 |
fibroblast growth factor 13 |
2258 |
Q92913 |
chrX: 138,614,731-139,222,777 |
|
FGF11 |
fibroblast growth factor 11 |
2256 |
Q92914 |
chr17: 7,438,273-7,444,937 |
|
FGF14 |
fibroblast growth factor 14 |
2259 |
Q92915 |
chr13: 101,710,804-102,402,457 |
|
SMARCC1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
6599 |
Q92922 |
chr3: 47,585,272-47,782,106 |
|
SMARCD1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 |
6602 |
Q96GM5 |
chr12: 50,084,972-50,100,712 |
|
HES6 |
hes family bHLH transcription factor 6 |
55502 |
Q96HZ4 |
chr2: 238,238,267-238,240,662 |
|
MARK4 |
MAP/microtubule affinity-regulating kinase 4 |
57787 |
Q96L34 |
chr19: 45,079,288-45,305,283 |
|
ATOH8 |
atonal bHLH transcription factor 8 |
84913 |
Q96SQ7 |
chr2: 85,751,344-85,788,066 |
|
FEZ1 |
fasciculation and elongation protein zeta 1 |
9638 |
Q99689 |
chr11: 125,445,745-125,496,317 |
|
MTR |
5-methyltetrahydrofolate-homocysteine methyltransferase |
4548 |
Q99707 |
chr1: 236,795,281-236,903,981 |
|
SIGMAR1 |
sigma non-opioid intracellular receptor 1 |
10280 |
Q99720 |
chr9: 34,634,722-34,637,809 |
|
OLFM1 |
olfactomedin 1 |
10439 |
Q99784 |
chr9: 135,075,422-135,121,179 |
|
PCDHAC1 |
protocadherin alpha subfamily C, 1 |
56135 |
Q9H158 |
chr5: 140,926,369-141,012,344 |
|
SDCBP2 |
syndecan binding protein 2 |
27111 |
Q9H190 |
chr20: 1,309,909-1,329,239 |
|
SEMA6A |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
57556 |
Q9H2E6 |
chr5: 116,443,616-116,574,934 |
|
BEX1 |
brain expressed X-linked 1 |
55859 |
Q9HBH7 |
chrX: 103,062,651-103,064,240 |
|
HES4 |
hes family bHLH transcription factor 4 |
57801 |
Q9HCC6 |
chr1: 998,962-1,000,172 |
|
NRN1 |
neuritin 1 |
51299 |
Q9NPD7 |
chr6: 5,997,999-6,007,605 |
|
MBNL1 |
muscleblind like splicing regulator 1 |
4154 |
Q9NR56 |
chr3: 152,243,828-152,465,780 |
|
RBFOX1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
54715 |
Q9NWB1 |
chr16: 5,239,802-7,713,338 |
|
STMN3 |
stathmin 3 |
50861 |
Q9NZ72 |
chr20: 63,639,705-63,657,682 |
|
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
51232 |
Q9NZV1 |
chr2: 36,355,926-36,551,135 |
|
DOK5 |
docking protein 5 |
55816 |
Q9P104 |
chr20: 54,475,597-54,651,171 |
|
CNTN3 |
contactin 3 |
5067 |
Q9P232 |
chr3: 74,262,568-74,521,140 |
|
MBD5 |
methyl-CpG binding domain protein 5 |
55777 |
Q9P267 |
chr2: 148,021,011-148,516,971 |
|
ATXN10 |
ataxin 10 |
25814 |
Q9UBB4 |
chr22: 45,671,798-45,845,307 |
|
EVL |
Enah/Vasp-like |
51466 |
Q9UI08 |
chr14: 99,971,449-100,144,236 |
|
MYT1L |
myelin transcription factor 1-like |
23040 |
Q9UL68 |
chr2: 1,789,113-2,331,260 |
|
INTU |
inturned planar cell polarity protein |
27152 |
Q9ULD6 |
chr4: 127,623,271-127,726,737 |
|
PCDHA7 |
protocadherin alpha 7 |
56141 |
Q9UN72 |
chr5: 140,834,248-141,012,344 |
|
PCDHA6 |
protocadherin alpha 6 |
56142 |
Q9UN73 |
chr5: 140,827,958-141,012,344 |
|
PCDHA4 |
protocadherin alpha 4 |
56144 |
Q9UN74 |
chr5: 140,806,929-141,012,344 |
|
ARHGAP26 |
Rho GTPase activating protein 26 |
23092 |
Q9UNA1 |
chr5: 142,770,384-143,229,011 |
|
IGSF9B |
immunoglobulin superfamily member 9B |
22997 |
Q9UPX0 |
chr11: 133,908,564-133,956,985 |
|
ITM2B |
integral membrane protein 2B |
9445 |
Q9Y287 |
chr13: 48,233,158-48,270,357 |
|
PCDHB3 |
protocadherin beta 3 |
56132 |
Q9Y5E6 |
chr5: 141,100,473-141,103,827 |
|
PCDHA8 |
protocadherin alpha 8 |
56140 |
Q9Y5H6 |
chr5: 140,841,187-141,012,344 |
|
PCDHA5 |
protocadherin alpha 5 |
56143 |
Q9Y5H7 |
chr5: 140,821,604-141,012,344 |
|
PCDHA3 |
protocadherin alpha 3 |
56145 |
Q9Y5H8 |
chr5: 140,801,028-141,012,344 |
|
PCDHA2 |
protocadherin alpha 2 |
56146 |
Q9Y5H9 |
chr5: 140,794,852-141,012,344 |
|
PCDHA11 |
protocadherin alpha 11 |
56138 |
Q9Y5I1 |
chr5: 140,868,183-141,012,344 |
|
PCDHA10 |
protocadherin alpha 10 |
56139 |
Q9Y5I2 |
chr5: 140,855,883-141,012,344 |
|
PCDHA1 |
protocadherin alpha 1 |
56147 |
Q9Y5I3 |
chr5: 140,786,136-141,012,347 |
|
PCDHAC2 |
protocadherin alpha subfamily C, 2 |
56134 |
Q9Y5I4 |
chr5: 140,966,235-141,012,344 |
|
MAFB |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B |
9935 |
Q9Y5Q3 |
chr20: 40,685,848-40,689,240 |
|
BZW2 |
basic leucine zipper and W2 domains 2 |
28969 |
Q9Y6E2 |
chr7: 16,646,131-16,706,523 |